Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07107139 · ClinicalTrials.gov registry record · NA

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

A NA study of Smokeless Tobacco, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07107139 is a NA study of Smokeless Tobacco that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 50 participants, below the 227-participant average among 3 other Smokeless Tobacco trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07107139, a NA study of Smokeless Tobacco, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.

Conditions Studied

Interventions

  • OTHER Copenhagen group
  • OTHER Snus group

Study Locations (1)

New York

  • Roswell Park - Buffalo

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-03-30
Est. Completion 2027-03-01
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT07107139

The ClinicalTrials.gov registry entry for NCT07107139 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 3 other Smokeless Tobacco trials with a reported enrollment target (78% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smokeless Tobacco appearing as the primary indexed condition, and to 2 interventions - of which Copenhagen group is the first listed.

NCT07107139 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07107139 about?

NCT07107139 is a clinical study titled "Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects". This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.

What is the current status of trial NCT07107139?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-30. Estimated completion is 2027-03-01.

What conditions does trial NCT07107139 study?

This clinical trial studies the following conditions: Smokeless Tobacco.

What interventions are being tested in trial NCT07107139?

The interventions under investigation include: Copenhagen group (OTHER), Snus group (OTHER).

Who is sponsoring clinical trial NCT07107139?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07107139 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smokeless Tobacco

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.